Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-14
Publisher
Informa UK Limited
Online
2020-09-30
DOI
10.1080/14656566.2020.1822326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
- (2019) Ganesh Raghu et al. Lancet Respiratory Medicine
- Diagnostic Likelihood Thresholds that Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis
- (2019) Simon L.F. Walsh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
- (2019) Toby M Maher et al. Lancet Respiratory Medicine
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
- (2019) Kevin R. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy inhibition-mediated epithelial–mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis
- (2019) Charlotte Hill et al. Cell Death & Disease
- Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy
- (2019) Masahiro Tahara et al. BMC Pulmonary Medicine
- Pamrevlumab in idiopathic pulmonary fibrosis
- (2019) Athol U Wells Lancet Respiratory Medicine
- Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
- (2019) Antonella Caminati et al. European Respiratory Review
- Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis
- (2019) Masatoshi Kanayama et al. SURGERY TODAY
- Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
- (2019) SongYi Han et al. Scientific Reports
- Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece
- (2019) Argyris Tzouvelekis et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
- (2018) Lyne Gagnon et al. AMERICAN JOURNAL OF PATHOLOGY
- Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated CT Analysis
- (2018) Joseph Jacob et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
- (2018) Carlo Vancheri et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis
- (2018) Rachel S. Knipe et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Hydroxychloroquine: An old drug with new relevance
- (2018) E. A. SHIPPEY et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants
- (2018) Charlotte H. Maden et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial
- (2018) Matthew Hammond et al. Trials
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
- (2018) Toby M Maher et al. Lancet Respiratory Medicine
- Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
- (2018) David A Lynch et al. Lancet Respiratory Medicine
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
- (2018) Scott M. Palmer et al. CHEST
- Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
- (2018) Martin Kolb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
- (2018) Bruno Crestani et al. Lancet Respiratory Medicine
- Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial
- (2018) Ganesh Raghu et al. Lancet Respiratory Medicine
- Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
- (2018) Dina Visca et al. Lancet Respiratory Medicine
- The Potential Impact of Azithromycin in Idiopathic Pulmonary Fibrosis
- (2018) Claudio Macaluso et al. EUROPEAN RESPIRATORY JOURNAL
- Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis
- (2018) Kevin K. Brown et al. RESPIRATORY MEDICINE
- Pirfenidone improves survival in IPF: results from a real-life study
- (2018) George A. Margaritopoulos et al. BMC Pulmonary Medicine
- Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease
- (2017) Michele R. Schaeffer et al. EUROPEAN RESPIRATORY JOURNAL
- Autotaxin inhibitors: a patent review (2012-2016)
- (2017) Aikaterini Nikolaou et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Idiopathic pulmonary fibrosis
- (2017) Luca Richeldi et al. LANCET
- An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)
- (2017) Ulrich Costabel et al. RESPIRATION
- Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?
- (2017) Steven D. Nathan et al. RESPIRATORY MEDICINE
- Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia
- (2017) Leona M. Dowman et al. RESPIROLOGY
- Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo
- (2017) Christian A. Kuttruff et al. ACS Medicinal Chemistry Letters
- Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis
- (2017) Li Liu et al. Scientific Reports
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
- (2017) Steven D Nathan et al. Lancet Respiratory Medicine
- Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
- (2017) Kerri A Johannson et al. Lancet Respiratory Medicine
- An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
- (2017) Toby M Maher et al. Lancet Respiratory Medicine
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
- (2016) Ulrich Costabel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
- (2016) Harold R. Collard et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Drug Treatment of Idiopathic Pulmonary Fibrosis
- (2016) William J. Canestaro et al. CHEST
- FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
- (2016) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
- (2016) Bernt van den Blink et al. EUROPEAN RESPIRATORY JOURNAL
- Hydroxychloroquine in systemic lupus erythematosus (SLE)
- (2016) C. Ponticelli et al. Expert Opinion On Drug Safety
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart–Lung Transplant Report—2016; Focus Theme: Primary Diagnostic Indications for Transplant
- (2016) Roger D. Yusen et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
- (2016) David N. O’Dwyer et al. JOURNAL OF IMMUNOLOGY
- The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience
- (2016) Takashi Ono et al. Radiation Oncology
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
- (2016) Luca Richeldi et al. RESPIRATORY MEDICINE
- Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
- (2016) Steven D Nathan et al. THORAX
- Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
- (2016) Martin Kolb et al. THORAX
- Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis
- (2016) Huaping Chen et al. Nature Communications
- Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
- (2016) Michael Kreuter et al. Lancet Respiratory Medicine
- Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
- (2016) Gareth Hughes et al. Journal of Clinical Medicine
- SFTPA2Mutations in Familial and Sporadic Idiopathic Interstitial Pneumonia
- (2015) Coline H. M. van Moorsel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ten things you should know about protein kinases: IUPHAR Review 14
- (2015) Doriano Fabbro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Aspiration-Related Pulmonary Syndromes
- (2015) Xiaowen Hu et al. CHEST
- Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm
- (2015) Christopher J. Ryerson et al. EUROPEAN RESPIRATORY JOURNAL
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
- (2015) Paul W. Noble et al. EUROPEAN RESPIRATORY JOURNAL
- Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
- (2015) Banu A. Karimi-Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis. An Integral Model
- (2014) Moisés Selman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
- (2014) Phillip L. Molyneaux et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
- (2014) Enrico Conte et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
- (2014) Takashi Ogura et al. EUROPEAN RESPIRATORY JOURNAL
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
- (2014) Paolo Fraticelli et al. ARTHRITIS RESEARCH & THERAPY
- Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
- (2014) MeiLan K Han et al. Lancet Respiratory Medicine
- Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis
- (2013) Maureen R. Horton et al. ANNALS OF INTERNAL MEDICINE
- Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan
- (2013) Ganesh Raghu ANNALS OF INTERNAL MEDICINE
- Mechanistic links between aging and lung fibrosis
- (2013) Victor J. Thannickal BIOGERONTOLOGY
- Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction
- (2013) MeiLan K. Han et al. CHEST
- Clinical Features and Outcomes in Combined Pulmonary Fibrosis and Emphysema in Idiopathic Pulmonary Fibrosis
- (2013) Christopher J. Ryerson et al. CHEST
- Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
- (2013) Yong Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- Sleep Oxygen Desaturation Predicts Survival in Idiopathic Pulmonary Fibrosis
- (2013) Likurgos Kolilekas et al. Journal of Clinical Sleep Medicine
- Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
- (2013) Joyce S Lee et al. Lancet Respiratory Medicine
- The Alveolar Epithelium Determines Susceptibility to Lung Fibrosis in Hermansky-Pudlak Syndrome
- (2012) Lisa R. Young et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2012) Nikos Oikonomou et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Tyrosine kinase signaling in fibrotic disorders
- (2012) Christian Beyer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial
- (2012) Nicole M Ryan et al. LANCET
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
- (2012) Ludmila Shulgina et al. THORAX
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial
- (2011) R. F. Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease
- (2011) Dinesh Khanna et al. ARTHRITIS AND RHEUMATISM
- Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center
- (2011) Janet Pope et al. ARTHRITIS AND RHEUMATISM
- Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
- (2011) Eoin P. Judge et al. EUROPEAN RESPIRATORY JOURNAL
- Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8–mediated activation of TGF-β
- (2011) Hideya Kitamura et al. JOURNAL OF CLINICAL INVESTIGATION
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cough predicts prognosis in idiopathic pulmonary fibrosis
- (2011) CHRISTOPHER J. RYERSON et al. RESPIROLOGY
- Surfactant Protein C Mutations Are the Basis of a Significant Portion of Adult Familial Pulmonary Fibrosis in a Dutch Cohort
- (2010) Coline H. M. van Moorsel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interstitial lung diseases in children
- (2010) Annick Clement et al. Orphanet Journal of Rare Diseases
- Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis
- (2010) JEFFREY J. SWIGRIS et al. RESPIROLOGY
- Low-dose oral interferon possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients
- (2010) L. O. Lutherer et al. THORAX
- Imatinib Treatment for Idiopathic Pulmonary Fibrosis
- (2009) Craig E. Daniels et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen
- (2009) Markella Ponticos et al. ARTHRITIS AND RHEUMATISM
- Idiopathic Pulmonary Fibrosis and Emphysema
- (2009) Mayra Mejía et al. CHEST
- Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
- (2009) Evans R. Fernández Pérez et al. CHEST
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
- Native Lung Complications in Single-lung Transplant Recipients and the Role of Pneumonectomy
- (2009) Christopher S. King et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults
- (2009) C.M. Rubino et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer
- (2008) Yongyu Wang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Computed Tomography Findings in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2008) Masanori Akira et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- c-Jun N-Terminal Kinase 1 Is Required for the Development of Pulmonary Fibrosis
- (2008) John F. Alcorn et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Serial Development of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
- (2008) Steven D. Nathan et al. RESPIRATION
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
- (2007) Talmadge E. King et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now